OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
600527$2.5356

Jiangsu Jiangnan High Polymer Fiber Co Ltd

Specialty ChemicalsVerified

Jiangsu Jiangnan High Polymer Fiber Co Ltd maintains a strong liquidity position, with a current ratio of 25.97, indicating a significant buffer of current assets over current liabilities. The company's market capitalization stands at 4.38 billion CNY, with a price-to-earnings ratio of 207.73 and a price-to-book ratio of 2.12, suggesting a relatively high valuation compared to its book value. The company's equity base is robust, with total equity of 2.07 billion CNY, and it carries minimal long-term debt of 8.38 million CNY, contributing to a debt-to-equity ratio of 0.0. Profitability metrics for the company are modest, with a return on equity (ROE) of 1.02% and a return on assets (ROA) of 0.98%, both below the typical thresholds for strong performance in the Specialty Chemicals industry. The company's operating income of 22.58 million CNY and net income of 21.09 million CNY reflect a narrow margin, with a gross profit of 52.32 million CNY on total revenue of 519.65 million CNY. These figures suggest that the company is operating in a competitive environment with limited pricing power. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification may expose the company to regional economic fluctuations and regulatory changes. The company's capital expenditures for the period were negative at -6.25 million CNY, indicating a reduction in investment in physical assets. Looking ahead, the company's growth trajectory is uncertain, with no specific revenue growth projections provided in the available data. The company's free cash flow of 18.53 million CNY and operating cash flow of 50.59 million CNY suggest a positive cash flow position, which could support future growth initiatives or shareholder returns. However, the company's high price-to-earnings and price-to-book ratios may indicate that the market is pricing in future growth that has yet to materialize. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could pose a liquidity challenge if cash flow from operations were to decline. The company's low dilution risk is supported by the absence of significant dilution sources in the available data. The company's minimal long-term debt and strong equity base further mitigate financial risk. Recent events and filings do not provide specific details on strategic initiatives or material changes in the company's operations. The company's financial statements do not disclose any recent acquisitions, divestitures, or major capital projects. The absence of detailed information on recent events may limit the ability to assess the company's strategic direction and operational performance.

30-day price · 600527+0.01 (+0.4%)
Low$2.46High$3.50Close$2.62As of25 May, 00:00 UTC
Profile
CompanyJiangsu Jiangnan High Polymer Fiber Co Ltd
Ticker600527.SS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Jiangsu Jiangnan High Polymer Fiber Co Ltd is a Chinese company engaged in the production and sale of high polymer fibers, primarily generating revenue through the manufacturing and distribution of chemical products.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry, with a classification confidence of 0.92.

Jiangsu Jiangnan High Polymer Fiber Co Ltd maintains a strong liquidity position, with a current ratio of 25.97, indicating a significant buffer of current assets over current liabilities. The company's market capitalization stands at 4.38 billion CNY, with a price-to-earnings ratio of 207.73 and a price-to-book ratio of 2.12, suggesting a relatively high valuation compared to its book value. The company's equity base is robust, with total equity of 2.07 billion CNY, and it carries minimal long-term debt of 8.38 million CNY, contributing to a debt-to-equity ratio of 0.0. Profitability metrics for the company are modest, with a return on equity (ROE) of 1.02% and a return on assets (ROA) of 0.98%, both below the typical thresholds for strong performance in the Specialty Chemicals industry. The company's operating income of 22.58 million CNY and net income of 21.09 million CNY reflect a narrow margin, with a gross profit of 52.32 million CNY on total revenue of 519.65 million CNY. These figures suggest that the company is operating in a competitive environment with limited pricing power. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification may expose the company to regional economic fluctuations and regulatory changes. The company's capital expenditures for the period were negative at -6.25 million CNY, indicating a reduction in investment in physical assets. Looking ahead, the company's growth trajectory is uncertain, with no specific revenue growth projections provided in the available data. The company's free cash flow of 18.53 million CNY and operating cash flow of 50.59 million CNY suggest a positive cash flow position, which could support future growth initiatives or shareholder returns. However, the company's high price-to-earnings and price-to-book ratios may indicate that the market is pricing in future growth that has yet to materialize. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could pose a liquidity challenge if cash flow from operations were to decline. The company's low dilution risk is supported by the absence of significant dilution sources in the available data. The company's minimal long-term debt and strong equity base further mitigate financial risk. Recent events and filings do not provide specific details on strategic initiatives or material changes in the company's operations. The company's financial statements do not disclose any recent acquisitions, divestitures, or major capital projects. The absence of detailed information on recent events may limit the ability to assess the company's strategic direction and operational performance.
Key takeaways
  • The company has a strong liquidity position with a current ratio of 25.97.
  • Profitability is modest, with ROE and ROA below typical thresholds for the industry.
  • The company's revenue is concentrated in a single business segment, with no geographic diversification disclosed.
  • Free cash flow and operating cash flow are positive, supporting potential growth or shareholder returns.
  • The company's valuation is high, with a price-to-earnings ratio of 207.73 and a price-to-book ratio of 2.12.
  • The company carries minimal long-term debt, contributing to a low debt-to-equity ratio of 0.0.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$519.7M
Gross profit$52.3M
Operating income$22.6M
Net income$21.1M
R&D
SG&A
D&A
SBC
Operating cash flow$50.6M
CapEx-$6.2M
Free cash flow$18.5M
Total assets$2.15B
Total liabilities$82.6M
Total equity$2.07B
Cash & equivalents
Long-term debt$8.4M
Valuation
Market price$2.53
Market cap$4.38B
Enterprise value$4.39B
P/E207.7
Reported non-GAAP P/E
EV/Revenue8.4
EV/Op income194.4
EV/OCF86.8
P/B2.1
P/Tangible book2.1
Tangible book$2.07B
Net cash-$8.4M
Current ratio26.0
Debt/Equity0.0
ROA1.0%
ROE1.0%
Cash conversion2.4%
CapEx/Revenue-1.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
Metric600527Activity
Op margin4.3%5.5% medp25 -0.0% · p75 10.8%below median
Net margin4.1%4.1% medp25 0.1% · p75 8.8%above median
Gross margin10.1%20.5% medp25 12.4% · p75 29.7%bottom quartile
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-1.2%-6.2% medp25 -13.4% · p75 -2.6%top quartile
Debt / equity0.0%37.1% medp25 10.3% · p75 82.0%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-25 04:16 UTC#6be5e81e
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 00:24 UTCJob: c0610cce